Home > Quotes > GEVA > Press Releases
GEVA

Synageva BioPharma Corp. Press Releases

$39.87
*  
0.04
  negative  
0.1%
Get GEVA Alerts
*Delayed - data as of May 17, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Synageva BioPharma™ Joins the International MPS Network in Support of MPS Awareness Day 2013
05/15/2013 7:00AM - Business Wire

Synageva BioPharma™ Announces One Year of Treatment Data with Sebelipase Alfa in Late Onset LAL Deficiency
05/09/2013 7:01AM - Business Wire

Synageva BioPharma™ Reports First Quarter 2013 Financial Results
05/07/2013 4:05PM - Business Wire

Late Onset LAL Deficiency (CESD) Literature Review Published in the Journal of Hepatology
03/26/2013 7:01AM - Business Wire

Synageva BioPharma™ Reports 2012 Full Year Financial Results
03/11/2013 4:01PM - Business Wire

Synageva BioPharma™ to Host 2012 Fourth Quarter and Full Year Financial Results Conference Call on March 11
03/01/2013 12:15PM - Business Wire

Synageva BioPharma™ Joins NORD, EURORDIS, and The Global Genes Project in Support of Rare Disease Day 2013
02/28/2013 6:00AM - Business Wire

Synageva BioPharma™ to Present at the Cowen and Company 33rd Annual Health Care Conference
02/26/2013 11:08AM - Business Wire